Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients
Author:
Publisher
Elsevier BV
Reference28 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020
2. Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection;Goh;Ann Acad Med Singap,2020
3. Pharmacologic treatments for coronavirus disease 2019 (COVID-19);Sanders;JAMA,2020
4. Update on colchicine, 2017;Slobodnick;Rheumatology,2018
5. Alogenosis iatrogénica: una nueva enfermedad;Coiffman;Cirugía Plástica Ibero-Latinoamericana,2008
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overview of COVID-19 Pandemic: Its Management and Prevention in Light of the Indian Traditional Medicine System;Current Traditional Medicine;2023-08
2. Oxygen Saturation in Hospitalized COVID-19 Patients and Its Relation to Colchicine Treatment: A Retrospective Cohort Study with an Updated Systematic Review;Medicina;2023-05-12
3. Long-term use of colchicine: “The time to guard against chronic toxicity among patients of familial Mediterranean fever”;Egyptian Rheumatology and Rehabilitation;2023-04-03
4. Therapeutic Strategies for COVID-19 Patients: An Update;Infectious Disorders - Drug Targets;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3